Brian Skorney's
Stock Forecasts
12%
3/25 win trades
Price targets by Brian Skorney
Company name & ticker | Publish date | Price target | Price when posted | Source | Historical targets |
---|---|---|---|---|---|
![]() Applied Therapeutics, Inc. APLT | 9 months ago | $5 912.55% upside | $9.42 | StreetInsider | Previous targets (0) |
![]() Biogen Inc. BIIB | 10 months ago | $300 116.21% upside | $162.83 | StreetInsider | |
![]() Sarepta Therapeutics, Inc. SRPT | 10 months ago | $193 874.74% upside | $124.95 | StreetInsider | |
![]() Alumis Inc. Common Stock ALMS | 10 months ago | $25 424.10% upside | $11.23 | StreetInsider | Previous targets (0) |
![]() Alto Neuroscience, Inc. ANRO | 11 months ago | $10 185.71% upside | $14.53 | StreetInsider | |
![]() Amgen Inc. AMGN | 11 months ago | $215 -27.70% downside | $330.92 | StreetInsider | Previous targets (0) |
![]() Regeneron Pharmaceuticals, Inc. REGN | 11 months ago | $940 63.53% upside | $1,091.98 | StreetInsider | Previous targets (0) |
![]() Biohaven Pharmaceutical Holding Company Ltd. BHVN | 12 months ago | $60 287.34% upside | $46.56 | StreetInsider | |
![]() Nurix Therapeutics, Inc. NRIX | 12 months ago | $26 162.89% upside | $24.44 | TheFly | Previous targets (0) |
![]() Mirum Pharmaceuticals, Inc. MIRM | about 1 year ago | $44 -32.47% downside | $38.96 | TheFly | |
![]() Gilead Sciences, Inc. GILD | about 1 year ago | $80 -31.97% downside | $69.21 | StreetInsider | Previous targets (0) |
![]() Lexeo Therapeutics, Inc. Common Stock LXEO | about 1 year ago | $28 485.77% upside | $18.19 | TheFly | Previous targets (0) |
![]() Crinetics Pharmaceuticals, Inc. CRNX | over 1 year ago | $62 105.02% upside | $49.13 | StreetInsider | Previous targets (0) |
![]() Soleno Therapeutics, Inc. SLNO | over 1 year ago | $72 7.76% upside | $47.64 | StreetInsider | Previous targets (0) |
![]() Marinus Pharmaceuticals, Inc. MRNS | over 1 year ago | $2 263.80% upside | $1.3 | StreetInsider | Previous targets (0) |
Other analysts covering same stocks
Geoff Porges
Leerink Partners
100%
win rate
Andrew Galler
Wolfe Research
100%
win rate
Zhiqiang Shu
Berenberg Bank
66.67%
win rate
Steve Chesney
Atlantic Equities
60%
win rate
Olivia Brayer
Cantor Fitzgerald
60%
win rate
Tyler Van Buren
Cowen & Co.
50%
win rate
Evan Seigerman
Loop Capital Markets
50%
win rate
Charles Duncan
Cantor Fitzgerald
40%
win rate